ESTABLISHMENT LABS HLDGS
Research ESTABLISHMENT LABS HLDGS (3E0) on Bullrun: market cap EUR 2.17B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3E0
- ExchangeF
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 2.17B
- Financial periodQ4 2025
- RevenueEUR 64.62M
- Net income-EUR 2.62M
- Free cash flow-EUR 1.82M
- Gross margin70.5%
Valuation Snapshot
latest market cap is EUR 2.17B.
About ESTABLISHMENT LABS HLDGS
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc.
Frequently asked questions
What is ESTABLISHMENT LABS HLDGS's market cap?
ESTABLISHMENT LABS HLDGS's market capitalization is EUR 2.17B.
What does ESTABLISHMENT LABS HLDGS do?
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States.